Fulcrum Therapeutics Inc (NASDAQ:FULC)
| 8.64 BATS BZX Real-Time Price As of 10:43am ET |  +0.17 / +2.01%Today’s Change | 4.37 Today|||52-Week Range 22.96 | -48.08% Year-to-Date |
Latest FULC News | Press Releases
| Dyne Therapeutics on deck for IPO Aug 26 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 8.47 |
| Today’s open | 8.49 |
| Day’s range | 8.44 - 8.64 |
| Volume | 226 |
| Average volume (3 months) | 157,045 |
| Market cap | $210.6M |
Data as of 10:43am ET, 09/18/2020
Growth & Valuation
| Earnings growth (last year) | -384.74% |
| Earnings growth (this year) | +66.05% |
| Earnings growth (next 5 years) | +2.87% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.99 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| EVLOEvelo Biosciences In... | +0.06 | +1.21% |
| SMMTSummit Therapeutics ... | 0.00 | 0.00% |
| LQDALiquidia Technologie... | +0.22 | +3.68% |
| ABUSArbutus Biopharma Co... | +0.04 | +1.34% |
Data as of 10:45am ET, 09/18/2020
Financials
| Next reporting date | November 12, 2020 |
| EPS forecast (this quarter) | -$0.66 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$82.7M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
